Timothy Chevassut

784 total citations
15 papers, 249 citations indexed

About

Timothy Chevassut is a scholar working on Infectious Diseases, Hematology and Genetics. According to data from OpenAlex, Timothy Chevassut has authored 15 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in Timothy Chevassut's work include COVID-19 Clinical Research Studies (5 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Timothy Chevassut is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Timothy Chevassut collaborates with scholars based in United Kingdom, United States and Spain. Timothy Chevassut's co-authors include Kate Milne, Eleni E Ladikou, Simon Stoneham, Ramy Saad, Barbara J. Philips, William E. Arter, Barbara Phillips, Stephen Drage, Chi Eziefula and Klaus Fenchel and has published in prestigious journals such as Blood, Journal of Neurology Neurosurgery & Psychiatry and Oncology.

In The Last Decade

Timothy Chevassut

15 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Chevassut United Kingdom 6 160 67 56 54 38 15 249
Kate Milne United Kingdom 4 148 0.9× 62 0.9× 37 0.7× 54 1.0× 15 0.4× 6 196
Grerk Sutamtewagul United States 9 84 0.5× 44 0.7× 60 1.1× 66 1.2× 66 1.7× 26 268
Daniella A. Spittle United Kingdom 6 143 0.9× 69 1.0× 46 0.8× 52 1.0× 39 1.0× 12 269
Fakiha Siddiqui United States 9 50 0.3× 38 0.6× 39 0.7× 129 2.4× 20 0.5× 49 301
Sukrita Bhattacharjee India 4 190 1.2× 79 1.2× 17 0.3× 18 0.3× 14 0.4× 5 334
M. V. Tretyakova Russia 8 65 0.4× 35 0.5× 18 0.3× 31 0.6× 15 0.4× 56 199
Arabesque Parker Canada 6 57 0.4× 31 0.5× 26 0.5× 38 0.7× 73 1.9× 11 256
Adriana Torri Italy 8 170 1.1× 48 0.7× 15 0.3× 9 0.2× 29 0.8× 13 285
Massimiliano Monticelli Italy 5 169 1.1× 64 1.0× 54 1.0× 6 0.1× 64 1.7× 8 356
Ottavio Zucchetti Italy 6 157 1.0× 76 1.1× 17 0.3× 14 0.3× 49 1.3× 11 284

Countries citing papers authored by Timothy Chevassut

Since Specialization
Citations

This map shows the geographic impact of Timothy Chevassut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Chevassut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Chevassut more than expected).

Fields of papers citing papers by Timothy Chevassut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Chevassut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Chevassut. The network helps show where Timothy Chevassut may publish in the future.

Co-authorship network of co-authors of Timothy Chevassut

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Chevassut. A scholar is included among the top collaborators of Timothy Chevassut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Chevassut. Timothy Chevassut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ladikou, Eleni E, et al.. (2022). Lymphocytosis and chronic lymphocytic leukaemia: investigation and management. Clinical Medicine. 22(3). 225–229. 4 indexed citations
2.
Weaving, Gary, et al.. (2021). Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers. Clinical Medicine. 21(3). e300–e305. 2 indexed citations
3.
Shahvisi, Arianne, et al.. (2021). Impact of affluence on the local spread of SARS-CoV2 during the first wave of the COVID-19 pandemic. Public Health in Practice. 2. 100141–100141. 1 indexed citations
4.
Ladikou, Eleni E, Kate Milne, William E. Arter, et al.. (2020). Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?. Clinical Medicine. 20(5). e178–e182. 99 indexed citations
5.
Chevassut, Timothy, et al.. (2020). Chloroquine and COVID-19 – a potential game changer?. Clinical Medicine. 20(3). 278–281. 19 indexed citations
6.
Stoneham, Simon, Kate Milne, Eleni E Ladikou, et al.. (2020). Thrombotic risk in COVID-19: a case series and case–control study. Clinical Medicine. 20(4). e76–e81. 62 indexed citations
7.
8.
Milne, Kate, et al.. (2020). Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived. Current Oncology Reports. 22(4). 36–36. 14 indexed citations
9.
Milne, Kate, et al.. (2020). The renin–angiotensin system – a therapeutic target in COVID-19?. Clinical Medicine. 20(4). e72–e75. 18 indexed citations
10.
11.
Adams, Peter D., Neil Robertson, Helen Stewart, et al.. (2018). BET Inhibitors Potentiate Activation of p53 and Killing of AML By MDM2 Inhibitors — a Candidate Combination Therapy. Blood. 132(Supplement 1). 3912–3912. 2 indexed citations
12.
Dempke, Wolfram C. M., Klaus Fenchel, Peter Uciechowski, & Timothy Chevassut. (2017). Targeting Developmental Pathways: The Achilles Heel of Cancer?. Oncology. 93(4). 213–223. 19 indexed citations
13.
Carroll, Liam, et al.. (2016). CLL, A RARE BUT TREATABLE CAUSE OF LONGITUDINALLY EXTENSIVE MYELITIS. Journal of Neurology Neurosurgery & Psychiatry. 87(12). e1.103–e1. 1 indexed citations
14.
Narwani, Vishal, Joseph Gabriel, Kevin Boyd, & Timothy Chevassut. (2014). Absolute Lymphocyte Count at Day 29 of Treatment Is a Powerful Predictor of Outcome in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 15(4). 222–226. 3 indexed citations
15.
Knapper, Steven, Timothy Chevassut, Rafael F. Duarte, et al.. (2013). Elacytarabine in relapsed/refractory acute myeloid leukaemia: An evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile. Leukemia Research. 38(3). 346–351. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kate Milne Breakdown of academic impact, for papers by Grerk Sutamtewagul Breakdown of academic impact, for papers by Daniella A. Spittle Breakdown of academic impact, for papers by Fakiha Siddiqui Breakdown of academic impact, for papers by Sukrita Bhattacharjee Breakdown of academic impact, for papers by M. V. Tretyakova Breakdown of academic impact, for papers by Arabesque Parker Breakdown of academic impact, for papers by Adriana Torri Breakdown of academic impact, for papers by Massimiliano Monticelli Breakdown of academic impact, for papers by Ottavio Zucchetti
Rankless by CCL
2026